Sensitivity analysis of FDA´s benchmark nozzle regarding in vitro imperfections - Do we need asymmetric CFD benchmarks?
Modern technologies and methods such as computer simulation, so-called in silico methods, foster the development of medical devices. For accelerating the uptake of computer simulations and to increase credibility and reliability the U.S. Food and Drug Administration organized an inter-laboratory rou...
Main Authors: | Stiehm Michael, Brandt-Wunderlich Christoph, Siewert Stefan, Schmitz Klaus-Peter, Grabow Niels, Goubergrits Leonid, Kühne Titus, Poon Eric K. W., Ooi Andrew, Barlis Peter |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-09-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/cdbme.2020.6.issue-3/cdbme-2020-3020/cdbme-2020-3020.xml?format=INT |
Similar Items
-
Numerical simulation of pulsatile flow through a coronary nozzle model based on FDA’s benchmark geometry
by: Stiehm Michael, et al.
Published: (2017-09-01) -
Flow Structures on a Planar Food and Drug Administration (FDA) Nozzle at Low and Intermediate Reynolds Number
by: Adrián Corrochano, et al.
Published: (2021-12-01) -
Acrylamide in Food – EU versus FDA Approaches
by: Gabriel Mustăţea, et al.
Published: (2015-11-01) -
Target Detection Performance Analysis of FDA-MIMO Radar
by: Yu Zhu, et al.
Published: (2019-01-01) -
Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01)